What are the responsibilities and job description for the Executive Director/Vice President, Oligonucleotide Chemistry position at Tessera Therapeutics?
Your experience includes…
Find out more about this role by reading the information below, then apply to be considered.
- PhD in synthetic organic chemistry or process chemistry, and 13 years of relevant experience.
- Deep understanding of modern methods in synthetic chemistry with an emphasis on nucleosides, nucleotides and oligonucleotide synthesis, and purification and analytical characterization as applied to nucleic acid therapeutics.
- Oligonucleotide manufacturing including CRO and CMO capabilities, familiarity with GMP requirements.
- Contributions to IND, BLA and regulatory filings.
- Strong organizational leadership skills with a proven track record in setting vision / strategy and managing team execution to achieve key company milestones.
- Lead efforts to identify emerging trends in the oligonucleotide therapeutics field and maintain awareness of the competitive landscape.
- Prior experience with long oligos via chemical synthesis or ligation is desirable.
You are interested in…
About you :
You are an experienced leader with a proven track record of scientific excellence in the oligonucleotide chemistry space. You have demonstrated success in team leadership / organization, platform building and development of oligos including a strong publication and patent record. You have hands-on experience driving technologies towards the clinics including knowledge related to IND filing.
Leadership Structure :
This position reports to : Sandeep Nema – Senior Vice President, Technical Development.
Company Summary :
Tessera Therapeutics is pioneering Gene Writing— a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine, building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.
More about Tessera Therapeutics :
Tessera is proud to be an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, age, sex, national origin, disability status, marital status, genetics, protected veteran status, citizenship status, sexual orientation, gender identity or expression, or any other characteristic identified by federal, state, or local laws where we operate. Tessera provides reasonable accommodations to qualified applicants and employees with disabilities.
J-18808-Ljbffr
